Risk factors of migraine-related brain white matter hyperintensities: an investigation of 186 patients
2011

Risk Factors for White Matter Changes in Migraine Patients

Sample size: 186 publication 10 minutes Evidence: moderate

Author Information

Author(s): Trauninger Anita, Leél-Őssy Eszter, Kamson David Olayinka, Pótó László, Aradi Mihály, Kövér Ferenc, Imre Marianna, Komáromy Hedvig, Erdélyi-Botor Szilvia, Patzkó Ágnes, Pfund Zoltán

Primary Institution: Department of Neurology, University of Pécs

Hypothesis

What are the risk factors associated with migraine-related brain white matter hyperintensities?

Conclusion

Migraine patients with longer disease duration and higher attack frequency are more likely to have brain white matter hyperintensities.

Supporting Evidence

  • Migraine patients have a higher prevalence of white matter hyperintensities compared to the general population.
  • Longer disease duration is associated with a higher incidence of white matter hyperintensities.
  • Higher headache frequency correlates with the presence of white matter hyperintensities.
  • Elevated homocysteine levels are significantly associated with white matter hyperintensities.
  • Subclinical thyroid dysfunction is more common in migraine patients with white matter hyperintensities.

Takeaway

This study found that people with migraines who have had them longer and have more frequent attacks are more likely to have certain brain changes.

Methodology

The study analyzed clinical data from 186 migraine patients, comparing those with and without white matter hyperintensities using MRI.

Potential Biases

Potential selection bias due to exclusion criteria.

Limitations

The study excluded patients with major comorbidities, which may limit the generalizability of the findings.

Participant Demographics

186 migraine patients (156 females, 30 males; age range 18–58 years, mean age 36.4 years).

Statistical Information

P-Value

p=0.004 for disease duration, p=0.017 for attack frequency, p=0.009 for hyperhomocysteinemia, p=0.038 for thyroid dysfunction.

Confidence Interval

95% CI for OR: Disease duration (1.015-1.089), Attack frequency (1.026-1.321)

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1007/s10194-011-0299-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication